Hysteroscopic evaluation of intrauterine progesterone contraceptive system as a treatment for abnormal uterine bleeding.
Intrauterine Progesterone Contraceptive System has been used in twenty patients aged 45 to 52, affected by dysfunctional uterine bleeding due to glandular hyperplasia (6 cases), focal glandular hyperplasia (8 cases), cystic hyperplasia (4 cases) and adenomatous hyperplasia (2 cases). Hysteroscopy and endometrial biopsy were performed every two months after insertion of IPCS. Complete regression or clear improvement were observed in all cases. The question if regression may be considered permanent or temporary remains to be answered.
D000328:Adult; D001706:Biopsy; D003692:Delayed-Action Preparations; D004717:Endometrium / Q000473:pathology; D005260:Female; D006801:Humans; D006965:Hyperplasia; D007436:Intrauterine Devices, Medicated; D020706:Laparoscopes; D008796:Metrorrhagia / Q000188:drug therapy* / Q000473:pathology; D008875:Middle Aged; D011374:Progesterone / Q000008:administration & dosage* / Q000627:therapeutic use
D003692:Delayed-Action Preparations; D011374:Progesterone